• Gene Mutation May Be Key to Familial Pancreatic Cancer

    Updated: 2011-12-30 00:50:11
    Health News Gene Mutation May Be Key to Familial Pancreatic Cancer Print E-mail THURSDAY , Dec . 29 HealthDay News Individuals may face a higher hereditary risk for developing pancreatic cancer if they carry abnormalities in the so-called ATM gene , new research . reveals The finding , reported in an upcoming issue of Cancer Discovery stems from genetic-sequencing work conducted among 166 pancreatic cancer patients . For comparative purposes , 190 other individuals who did not have pancreatic cancer also underwent . sequencing The study was led by Alison Klein , an associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the National Familial Pancreas Tumor . Registry Noting that 10 percent of pancreatic cancer patients are from

  • Health Care Reform Battle Tops Health News for 2011

    Updated: 2011-12-30 00:50:11
    Health News Health Care Reform Battle Tops Health News for 2011 Print E-mail THURSDAY , Dec . 29 HealthDay News While no one story dominated health news in 2011, the ongoing debate over the legality of the new health care reform law was perhaps the most polarizing , with the case now set to go to the U.S . Supreme Court early in 2012. Supporters of the Patient Protection and Affordable Care Act which President Obama signed into law in 2010, claim the legislation will extend coverage to 30 million Americans . But opponents labeled it an unconstitutional intrusion of government upon personal rights , especially the individual mandate clause that requires Americans to purchase health insurance or face . fines Some of the law's provisions , such as allowing children to remain on their parents'

  • Studies suggest Avastin can help ovarian cancer patients

    Updated: 2011-12-29 22:35:32
    Two studies released in this week's New England Journal of Medicine suggest the drug Avastin may benefit some ovarian cancer patients. The two studies found that adding Avastin to chemotherapy treatment can stall the growth of cancer by almost four months. Avastin, which has the generic name Bevacizumab, stops the growth of blood vessels that feed cancerous tumors, [...]

  • Venezuela’s Chavez Accuses U.S. of Giving Latin American Leaders Cancer

    Updated: 2011-12-29 19:02:00
    . About Us Sponsored : by CTCA Cancer News Making Sense of Cancer Screening Updates It's important to discuss testing schedule with your doctor Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet Recipes Supplements Cancer Prevention

  • Avastin May Help Some With Ovarian Cancer Studies

    Updated: 2011-12-29 07:50:13
    : Health News Avastin May Help Some With Ovarian Cancer : Studies Print E-mail WEDNESDAY , Dec . 28 HealthDay News Two new studies suggest that the drug Avastin may lengthen progression-free survival by about four months for women with ovarian . cancer What isn't clear yet is whether adding Avastin bevacizumab will make a difference in overall survival . One study suggested it would , while the other study didn't find a difference in overall survival between two treatment . groups The bottom-line results are a 28 percent reduction in disease progression with patients on continued bevacizumab compared to the standard treatment group . There was a 3.8 month median difference in progression-free survival , said Dr . Robert Burger , author of one of the studies and director of the Women's

  • $800K Research Grant Awarded to Hollings Cancer Center

    Updated: 2011-12-21 14:46:23
    An $800,000 grant from the National Institutes of Health was recently awarded to Hollings Cancer Center at the Medical University of South Carolina. The funds will support  research into how genetics and race affect cancer diagnosis rates, initially focusing on breast and prostate cancers. The funds will also help establish the South Carolina Cancer Disparities Research Center, a collaboration between researchers from . . . → Read More: $800K Research Grant Awarded to Hollings Cancer Center

  • A Special Holiday Wish from DNA Genotek

    Updated: 2011-12-20 15:43:00
     Seasons Greetings veryone:Please click the ideo link for a special holiday video card from NA Genotek. The DNA Genotek Team  

  • Five Things You Should Know About Environmental Links to Breast Cancer (Forbes, 12/7/2011)

    Updated: 2011-12-08 22:24:40
    Amy Westervelt's article on Forbes.com does a great job of parcing through the intricacies of the Institue of Medicine's new report. Here's an excerpt, including a quote our president and CEO, Jeanne Rizzo...

  • New (yet not so new) report on breast cancer and the environment

    Updated: 2011-12-08 00:55:14
    Today the Institute of Medicine released a report, funded by Komen for the Cure, entitled Breast Cancer and the Environment: A Life Course Approach. Our President and CEO, Jeanne Rizzo, responded to the report...

  • Get Your GSA Counted

    Updated: 2011-12-06 22:56:58
    One of our sister organizations, the Gay, Lesbian & Straight Education Network (GLSEN), has asked the Center to help get the word out about its GSA Census. Here’s direction from GLSEN on how you can get involved:  Click Here to take the 2011 GSA Census and let your GSA’s needs in the safe schools movement be heard! How many GSAs exist in [...]

Current Feed Items | Previous Months Items

Nov 2011 | Oct 2011 | Sep 2011 | Aug 2011 | Jul 2011 | Jun 2011